Posts by Hayden Erwin

Technology Plus Science: New Company Model? – PharmaVOICE 2020 Year In Preview

Saama Founder and CEO, Suresh Katta was quoted in PharmaVOICE’s Special 2020 Year In Preview issue in a discussion on what might occur if Apple, Amazon, Google or another big technology company bought a pharma company. “Though the life-sciences industry faces a number of issues, purchasing a pharmaceutical company by tech giants would not solve its current…

Read More

Webinar: How a Former Pharma Executive Is Moving the Clinical Trial Industry Forward – November 12, 2019

Date: November 12, 2019 Link: https://go.saama.com/fireside-chat-amit-gulwadi-11-19 After four years at Celgene and nearly a decade at Bristol-Myers Squibb, Amit Gulwadi left pharma to join Saama as Senior Vice President, Clinical Innovations in 2018. In this webinar, Amit will explain how his direct knowledge of the problems that plague clinical trials is shaping his innovation roadmap. “Our…

Read More

SCDM Annual Conference 2019 – September 29-October 2, 2019

Date: September 29 – October 2, 2019 Venue: Baltimore, MD Event Website: https://scdm.org/event/scdm-2019-annual-conference/ Seize the opportunity to get involved and help shape the educational program of the SCDM 2019 Annual Conference taking place September 29 – October 2, 2019 in Baltimore! As SCDM is continuously looking for ways to improve its educational offering and provide an excellent…

Read More

Saama Data Analytics Platform Runs On Machine Learning

Senior VP of Clinical Innovations, Amit Gulwadi, was featured in an article from Clinical Research News on the different ways that the LSAC makes use of machine learning. “In the world of clinical development, information is stored in a multitude of places, from clinical trial management systems and electronic data capture systems to third-party labs…

Read More

Health Technology: The Merging Disciplines of Medicine and Innovation

Chief Strategy Officer, Sagar Anisingaraju, was quoted in a recent PharmaVOICE article discussing how to overcome the challenge of big data and AI’s relative “newness” within the pharma industry. “A clinical neural network would mean research sharing across thousands of studies conducted in different therapeutic areas by different companies,” Mr. Anisingaraju says. “This is one area where…

Read More

3rd Real-World Evidence Forum – July 15-16, 2019

Date: July 15-16, 2019 Venue: The Inn at Penn, Philadelphia, PA Event Website: https://exlevents.com/real-world-evidence-forum/ ExL is excited to bring you the 3rd Real-World Evidence Forum to bring together the industries leaders at a two-day educational summit where attendees will learn to drive down medical costs and improve both product safety and effectiveness while fulfilling the requests of regulators,…

Read More

Clinical Operations in Oncology Trials East Coast – July 10-11, 2019

Date: July 10-11, 2019 Venue: The Westin Waltham Boston Event Website: https://www.arena-international.com/oncologyusa/ The Clinical Operations in Oncology Trials East Coast event will be returning to Boston for its  8th year for another interactive and solution driven event. The event will provide 2 days of case studies, networking and thought provoking discussion with over 200 industry leading professionals.…

Read More

Saama Collaborates with Researchers to Assess Technology Adoption in Drug Development

Collaboration Continues Saama’s Commitment to Academic Alliances that Advance Clinical Operations CAMPBELL, CA – (July 9, 2019) – Saama Technologies, Inc. (“Saama”), a leading clinical data analytics company, today announced a collaboration with researchers at the Tufts Center for the Study of Drug Development (Tufts CSDD) at Tufts University School of Medicine to ascertain how…

Read More

Related Posts